Photo by atikahakhtar from unsplash
The SARS-CoV-2 pandemic has worsened since publication of our initial recommendations for the management of autoimmune bullous diseases (AIBDs) during the COVID-19 outbreak in April 2020.1 Based on the rapidly… Click to show full abstract
The SARS-CoV-2 pandemic has worsened since publication of our initial recommendations for the management of autoimmune bullous diseases (AIBDs) during the COVID-19 outbreak in April 2020.1 Based on the rapidly emerging increase of knowledge, this consensus of an expanded panel of international AIBD experts perceives as prosecution of the existing recommendations to promote optimal care during the pandemic.
Keywords:
management autoimmune;
recommendations management;
updated international;
autoimmune bullous;
bullous diseases
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!